Cost of GLP 1 Semaglutide Compounded Tirzepatide – How to Get Tirzepatide for $149

The cost of GLP-1 medications like semaglutide and compounded tirzepatide can vary dramatically in 2026 depending on where you buy them, whether you use insurance, and which provider or pharmacy you choose.

While brand-name injections Cost of GLP 1 Semaglutide Compounded Tirzepatide can still exceed $1,000 per month, compounded and telehealth options are now offering lower-cost alternatives that have quickly gained attention among weight-loss patients.

In this guide, we compare real semaglutide and tirzepatide pricing, explain why costs differ so much, and reveal the key things to verify before ordering compounded GLP-1 medications online.

Quick Answer: The cost of GLP-1 medications in 2026 ranges from as low as $99/month for compounded semaglutide to over $1,200/month for brand-name Wegovy without insurance. Compounded versions of semaglutide and tirzepatide offer the biggest savings, often 50% or more below brand-name prices, and are widely accessible through telehealth platforms. Insurance coverage, patient assistance programs, and direct-manufacturer options can also dramatically reduce what you pay out of pocket.

Key Takeaways

• Brand-name GLP-1 drugs (Ozempic, Wegovy, Mounjaro, Zepbound) cost $399–$1,200/month without insurance [1][2]
• Compounded semaglutide starts at $99–$149/month (oral) and $147–$299/month (injectable) [1]
• Compounded tirzepatide typically runs $250–$450/month through telehealth subscription services [3]
• Commercial insurance can reduce costs to $25–$150/month, but prior authorization is often required [3]
• Medicare coverage expansion begins July 2026 for qualifying beneficiaries with Type 2 diabetes or obesity-related conditions [4]
• Telehealth platforms are among the lowest-cost entry points, bundling medication, visits, and shipping into flat-rate plans [1]
• Compounded GLP-1s are not FDA-approved as finished drug products — patients trade regulatory assurance for significant cost savings [1][4]
• FDA issued new compounding guidance on April 1, 2026, clarifying compliance conditions as the national GLP-1 supply stabilizes [6]
• Delivery method matters: at-home self-injection is consistently cheaper than in-office administration [2]
• Tirzepatide costs more than semaglutide across all formats due to its dual-action mechanism and newer market position [2]

What Are GLP-1 Weight Loss Medications?

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of prescription medications that mimic a natural gut hormone to regulate blood sugar, suppress appetite, and slow digestion. Originally developed for Type 2 diabetes, they’ve become the most talked-about weight loss drugs in modern medicine.

The most widely used GLP-1 weight loss drugs include:

• Semaglutide — sold as Ozempic (diabetes), Wegovy (weight loss), and Rybelsus (oral tablet)
• Tirzepatide — sold as Mounjaro (diabetes) and Zepbound (weight loss), which targets both GLP-1 and GIP receptors
• Liraglutide — sold as Victoza and Saxenda, an older GLP-1 option still in use

Clinical trials have shown semaglutide can produce 10–15% average body weight loss, while tirzepatide has shown up to 20–22% in some studies. These aren’t magic pills — they work best alongside dietary changes and physical activity. But the results are real, and demand has surged accordingly.

For a deeper look at how these medications differ, see our guide on types of GLP-1 meds: semaglutide, tirzepatide and more.

The 3 Most Affordable GLP 1 Without Insurance (2026 Ranked)

🥇 #1 Best Overall: Zepbound (Triple-Action Option)

DirectMeds is a LegitScript-certified telehealth platform that connects patients with licensed U.S. physicians who evaluate whether compounded GLP-1 medications are clinically appropriate.

It is one of the most established providers in this space and is particularly well-suited to patients who want high-touch clinical oversight without paying brand-name prices.

How it works: Complete a secure online health intake form. A licensed medical provider reviews your profile and determines eligibility. If approved, your prescription is sent to a certified U.S. compounding pharmacy and medication is shipped directly to your door. All-inclusive pricing covers medical consultation, medication, and 24/7 support — no surprise charges.

◉ Clinical Note: DirectMeds’ LegitScript certification is a meaningful differentiator in this market. It requires compliance with pharmacy laws, prescription standards, and advertising guidelines — reducing the risk of receiving substandard compounded medications. For patients new to telehealth GLP-1 programs, this certification provides a meaningful layer of accountability. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Patients who want an established, verified provider with strong clinical support and are comfortable paying slightly more than the absolute floor price for greater peace of mind.

🥈#2 Best for Long-Term Cost Certainty: MyStart GLP-1

🥈 Silver Standard — Best Flat-Rate Pricing

👉 Check MyStart Eligibilit→

MyStart GLP-1 uses a unique flat-rate membership model where your medication cost is fixed regardless of how high your therapeutic dose increases over time. For patients who will be on GLP-1 therapy for 12 months or more, this pricing structure can save $600 to $1,800 annually compared to platforms that charge progressively more as doses escalate.

How it works: Pay a monthly membership ($79) plus a flat medication fee (e.g., $175 for compounded semaglutide). The combined total stays fixed at $254 per month from starter dose through maximum maintenance dose. Medical consultation, all medication, dedicated care team access, and nutritional coaching are included.

◉ Clinical Note: The flat-rate model is financially sound for long-term GLP-1 use. GLP-1 therapy is most effective when sustained for 12+ months, and avoiding dose-related price increases removes a common reason patients discontinue treatment early. The included nutritional coaching adds meaningful clinical value, as sustainable weight loss requires both medication and lifestyle change. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Patients committed to long-term treatment (12+ months) who want price certainty as doses increase, and who value behavioral coaching as part of their program.

Best for: People who want a more advanced GLP-1 approach at a reduced price. 👉 SKIP THE WAITLIST. START FOR $199

Thousands of people are losing weight with MyStart GLP-1 medications. People like you are transforming their lives, feeling better, and looking their best with the help of GLP-1 (Dual-Action Option) medications.

🥉 #3 Best for Absolute Lowest Entry Cost: MEDVi GLP-1

🥉 Bronze Standard — Lowest Entry Price

👉 Check MEDVi Eligibility→

MEDVi offers the most accessible entry price point in the compounded GLP-1 market, with starter doses beginning as low as $99 per month and a published price-match guarantee.

The platform provides both injectable and oral compounded GLP-1 options, giving prescribers flexibility to match the medication form to the patient. Clinical follow-up is primarily quarterly rather than monthly, which keeps costs lower but means less frequent dose adjustment guidance than the two options above.

How it works: Complete an online consultation. If qualified, your prescription is sent to a partner compounding pharmacy and medication is shipped to you within 48 hours. Customer support is available, and clinical check-ins are typically quarterly. No membership fees are charged on top of medication pricing.

◉ Clinical Note: MEDVi is a legitimate, cost-effective option for budget-focused patients who have researched compounded medications and are comfortable with less frequent clinical contact. Always ask your provider which specific compounding pharmacy fulfills your prescription — a reputable 503A or 503B state-licensed pharmacy is non-negotiable for safety. — Dr. Sarah Jenkins, Co-Author

🎯 Ideal for: Budget-focused patients who have done their research on compounded GLP-1 medications, are comfortable managing more of their own care independently, and want the lowest possible entry price with a price-match guarantee.

👉 START LOSING FOR $200 TODAY

What Is the Cost of GLP-1 Medications Without Insurance?

Without insurance, the cost of GLP-1 medications is significant — and varies widely depending on the drug, dose, and where you get it. Here’s a clear breakdown:

Brand-Name GLP-1 Pricing (2026)

Medication	Condition	Monthly Cost (No Insurance)
Ozempic (semaglutide)	Type 2 Diabetes	$800–$1,000
Wegovy (semaglutide)	Weight Loss	$1,000–$1,200
Mounjaro (tirzepatide)	Type 2 Diabetes	$399–$549
Zepbound (tirzepatide)	Weight Loss	$399–$549
Rybelsus (oral semaglutide)	Type 2 Diabetes	$900–$1,100

Brand-name semaglutide (Ozempic, Wegovy) without insurance costs $599–$1,200 per month, while brand-name tirzepatide (Mounjaro, Zepbound) ranges from $399–$549 per month [1]. Overall, GLP-1 medications can cost anywhere from $900 to $1,300 per month without insurance depending on the specific medication and delivery method [2].

Compounded GLP-1 Pricing (2026)

Medication	Format	Monthly Cost
Compounded Semaglutide	Oral (tablet/troche)	$99–$149
Compounded Semaglutide	Injectable (vial)	$147–$299
Compounded Tirzepatide	Injectable (vial)	$250–$450
LillyDirect Tirzepatide	Single-dose vials	$299–$499

Compounded semaglutide pricing starts at $99–$149/month for oral formats and $147–$299/month for injectables — representing 50% or greater savings compared to brand-name versions [1][2]. Compounded tirzepatide runs $250–$450/month through telehealth subscription services [3].

One important note: Compounded GLP-1 medications are not FDA-approved as finished products. They’re prepared by licensed compounding pharmacies and have been available partly due to shortage exemptions. The FDA issued updated compounding guidance on April 1, 2026, clarifying compliance conditions as the national supply stabilizes [6].

If you’re considering compounded options, it’s worth reading how compounded semaglutide differs from Ozempic before deciding.

How Does Insurance Coverage Affect the Cost of GLP-1 Drugs?

Insurance can dramatically cut what you pay — but getting coverage approved is rarely straightforward. Commercial insurance typically reduces GLP-1 costs to $25–$150/month, but coverage eligibility faces strict prior authorization requirements and clinical criteria [3].

What Insurance Typically Requires

Most insurers require you to meet at least one of these criteria before approving a GLP-1:

• BMI of 30 or higher (obesity diagnosis)
• BMI of 27 or higher plus a weight-related condition (Type 2 diabetes, hypertension, sleep apnea, high cholesterol)
• Documentation of prior weight loss attempts (diet programs, other medications)
• Physician-documented medical necessity

Some plans cover semaglutide for diabetes (Ozempic) but not for weight loss (Wegovy) — even though it’s the same active ingredient. This is a frustrating but common reality.

Medicare Coverage Update (July 2026)

A significant policy shift is underway. Medicare coverage expansion begins July 2026 for select beneficiaries, with coverage potentially ranging from $25–$150/month for those with qualifying conditions (Type 2 diabetes or obesity with related metabolic conditions) [4]. This reflects growing recognition of GLP-1 agents as medically necessary treatments, not lifestyle drugs.

If your insurer has denied coverage, don’t give up. Learn how to appeal an insurance denial for semaglutide — many appeals succeed with the right documentation.

Compounded vs. Brand-Name: Which Is the Better Value?

The honest answer: it depends on your priorities and risk tolerance.

Choose brand-name if:

• You have insurance coverage that makes it affordable
• You want full FDA-approval assurance
• You prefer the convenience of pre-filled auto-injector pens
• You’re managing Type 2 diabetes and need the specific approved formulation

Choose compounded if:

• You’re paying out of pocket and cost is the primary barrier
• You’ve been evaluated by a licensed provider and are a good candidate
• You’re comfortable with self-injection from a vial
• You understand the regulatory trade-offs involved

Tirzepatide tends to be more expensive than semaglutide across all formats due to its dual-action mechanism (targeting both GLP-1 and GIP receptors) and its newer market position [2]. If budget is your main concern, compounded semaglutide at $99–$299/month is the most affordable starting point.

For a detailed head-to-head, see our semaglutide vs. tirzepatide comparison for weight loss.

Common mistake: Many people assume compounded medications are identical to brand-name products. They use the same active ingredient, but formulation, inactive ingredients, and quality control standards differ. Always use a licensed, accredited compounding pharmacy.

How Do Telehealth Platforms Change the Cost of GLP-1 Access?

Telehealth has fundamentally changed who can access GLP-1 medications and at what price. Telehealth platforms offering compounded medications charge between $99–$149/month for complete service packages — including medication, telehealth visits, and shipping [1].

These all-inclusive subscription models typically cover:

• Initial consultation with a licensed provider
• Ongoing prescription management
• Monthly medication supply (compounded semaglutide or tirzepatide)
• Shipping directly to your door
• Dose adjustment support

This is a significant advantage over traditional clinic visits, where in-office administration significantly increases costs compared to at-home self-injection [2]. At-home vials are consistently more cost-effective than in-office administration for the same medication.

Popular telehealth models for compounded GLP-1s include:

• Flat-rate monthly subscriptions ($99–$299/month for semaglutide)
• Tiered pricing based on dose ($250–$450/month for tirzepatide) [3]
• Bundle plans that include nutrition coaching or metabolic labs

If you want to explore specific platforms, our review of GLP-1s without insurance covers the top telehealth options with pricing details.

What Patient Assistance Programs and Savings Strategies Actually Work?

Beyond insurance and compounding, there are several legitimate ways to reduce what you pay for GLP-1 medications.

Manufacturer Savings Programs

• Novo Nordisk (Ozempic/Wegovy): The Novo Nordisk Patient Assistance Program offers free medication to qualifying uninsured patients below certain income thresholds. The Wegovy savings card can reduce costs to as low as $0/month for eligible commercially insured patients.
• Eli Lilly (Mounjaro/Zepbound): The Lilly Insulin Value Program and Lilly Cares Foundation offer assistance for uninsured and underinsured patients. LillyDirect also sells tirzepatide single-dose vials at $299–$499/month — a lower-cost direct-to-consumer option for those wanting brand-name assurance [3].

GoodRx and Pharmacy Discount Cards

GoodRx and similar discount programs can reduce brand-name GLP-1 costs at participating pharmacies. Savings vary significantly by location and medication, but they’re worth checking before paying list price.

Finding the Cheapest Pharmacy

Prices for the same medication can vary by hundreds of dollars between pharmacies. Our guide to the cheapest pharmacy for semaglutide compares major chains and online pharmacies to help you find the best deal.

Long-Term Cost Planning

Here’s a realistic projection for a 12-month GLP-1 treatment course:

Option	Monthly Cost	Annual Cost
Brand-name Wegovy (no insurance)	$1,100	$13,200
Brand-name Zepbound (no insurance)	$500	$6,000
Compounded Semaglutide (injectable)	$250	$3,000
Compounded Tirzepatide	$350	$4,200
With commercial insurance	$75 avg.	$900
Medicare (post-July 2026)	$87 avg.	$1,044

These are estimates based on current market data [1][2][3][4]. Actual costs depend on your dose, provider, and location.

Who Qualifies for a GLP-1 Prescription?

Most prescribers follow FDA-approved criteria, though telehealth platforms may apply slightly different clinical standards.

Standard eligibility criteria:

• BMI ≥ 30 (obesity), OR
• BMI ≥ 27 with at least one weight-related health condition (Type 2 diabetes, hypertension, dyslipidemia, obstructive sleep apnea, or cardiovascular disease)
• No personal or family history of medullary thyroid carcinoma or MEN2 syndrome
• No history of pancreatitis (relative contraindication)
• Not pregnant or planning pregnancy

Who typically does NOT qualify:

• People with BMI under 27 without metabolic conditions
• Those with certain thyroid cancers or endocrine tumors
• Patients with severe gastrointestinal conditions

If you’re unsure whether you qualify, our guide on how to get semaglutide — prescription, providers, and access walks through the process step by step.

What Side Effects Should You Know Before Starting?

Understanding side effects isn’t just about safety — it affects whether you’ll stay on the medication long enough to see results, which directly impacts your cost-per-outcome.

Most common GLP-1 side effects (both semaglutide and tirzepatide):

• Nausea (most common, especially early on)
• Vomiting
• Diarrhea or constipation
• Fatigue
• Injection site reactions (for injectables)

Less common but serious:

• Pancreatitis (seek immediate care if you have severe abdominal pain)
• Gallbladder issues
• Increased heart rate
• Potential thyroid C-cell tumor risk (seen in animal studies; relevance in humans is still being studied)

Tirzepatide and semaglutide have similar side effect profiles, though tirzepatide’s dual-action mechanism may produce slightly different GI tolerability for some patients. Most side effects are dose-dependent and improve as your body adjusts.

Practical tip: Starting at the lowest dose and titrating up slowly is the most effective way to minimize side effects. Don’t rush the dose escalation just to see faster results.

Is the Compounded GLP-1 Market Here to Stay?

This is one of the most common questions right now, and the answer is nuanced. The national GLP-1 supply is beginning to stabilize as the semaglutide shortage ends, with compounded GLP-1s being phased out in some markets — though pharmacists anticipate compounded options will not disappear completely [7].

The FDA’s April 1, 2026 guidance clarified compliance conditions for compounding pharmacies, reflecting ongoing regulatory oversight [6]. Some compounders have already begun winding down production of semaglutide-based compounds, while tirzepatide compounding continues under different regulatory conditions.

What this means for you:

• If you’re currently on compounded semaglutide, ask your provider about transition planning
• Compounded tirzepatide remains more widely available for now
• Telehealth platforms are adapting quickly — many are pivoting to tirzepatide or exploring new formulations
• Prices may shift as supply dynamics change

For the latest on this, GoodRx has been tracking the compounded GLP-1 regulatory landscape closely [7].

Frequently Asked Questions

Q: How much do GLP-1 drugs cost without insurance in 2026? Brand-name GLP-1 medications cost $399–$1,200/month without insurance. Compounded versions start at $99/month for oral semaglutide and go up to $450/month for tirzepatide injectables [1][2].

Q: Is compounded semaglutide safe? Compounded semaglutide uses the same active ingredient as Ozempic and Wegovy but is prepared by compounding pharmacies rather than the original manufacturer. It’s not FDA-approved as a finished product. Using a licensed, accredited compounding pharmacy through a legitimate telehealth provider significantly reduces risk.

Q: What’s the cheapest GLP-1 medication available? Compounded oral semaglutide through telehealth platforms is currently the lowest-cost option, starting at $99–$149/month including medication, provider visits, and shipping [1].

Q: Does Medicare cover GLP-1 weight loss drugs? Starting July 2026, Medicare is expanding coverage for qualifying beneficiaries with Type 2 diabetes or obesity-related metabolic conditions, with estimated costs of $25–$150/month depending on the plan [4].

Q: How do I get a GLP-1 prescription? You need a prescription from a licensed provider. Options include your primary care doctor, an endocrinologist, a weight loss clinic, or a telehealth platform. Telehealth is often the fastest and most affordable route for initial access.

Q: Is tirzepatide better than semaglutide for weight loss? Clinical data suggests tirzepatide produces greater average weight loss (up to 20–22% vs. 10–15% for semaglutide in some studies). However, it costs more and is newer to market. The “better” choice depends on your health profile, budget, and how you respond to each medication.

Q: Can I use GoodRx for GLP-1 medications? Yes, GoodRx discounts apply at many pharmacies for brand-name GLP-1s and can reduce costs meaningfully. However, compounded versions are typically only available through specific telehealth platforms or compounding pharmacies and aren’t covered by GoodRx.

Q: What happens if I stop taking a GLP-1 medication? Most people regain a significant portion of lost weight after stopping GLP-1 medications. This is why long-term treatment planning — including cost sustainability — is an important part of the conversation with your provider.

Q: Are there international options for cheaper GLP-1 medications? Some patients explore purchasing GLP-1 medications from Canadian or European pharmacies, where prices can be lower. This carries legal and safety risks — medications purchased outside the U.S. are not regulated by the FDA, and quality cannot be guaranteed. Consult your provider before considering this route.

Q: How long do I need to take a GLP-1 medication? GLP-1 medications are generally considered long-term treatments. Most clinical guidelines suggest ongoing use for sustained weight management, similar to how blood pressure or cholesterol medications are managed. Your provider will help determine the right duration based on your goals and response.

Conclusion: Making the Cost of GLP-1 Work for You

The cost of GLP-1 medications is the single biggest barrier keeping people from treatments that genuinely work. But as this guide shows, the price range is wider than most people realize — from $99/month for compounded semaglutide to over $1,200/month for brand-name Wegovy without coverage.

Here’s your action plan:

1. Check your insurance first. Even if you’ve been denied before, the July 2026 Medicare expansion and evolving commercial coverage policies mean it’s worth re-checking.
2. Explore telehealth platforms. They offer the fastest access and lowest all-in costs for compounded options.
3. Ask about manufacturer assistance. Novo Nordisk and Eli Lilly both have programs for uninsured and underinsured patients.
4. Compare semaglutide vs. tirzepatide based on your budget and health goals — not just what’s most popular.
5. Plan for the long term. Build the monthly cost into your budget as a medical expense, not a short-term fix.

The medications are real. The results are real. And with the right strategy, the cost doesn’t have to be the reason you don’t start.

For more help navigating your options, explore our complete guide to semaglutide cost — monthly prices with and without insurance and our compounded tirzepatide overview.

Medical Disclaimer: The information on Healthfactsjournal.com is for educational and informational purposes only and is not intended as medical advice. These statements have not been evaluated by the FDA. Always seek the advice of a qualified healthcare provider regarding any medical condition or treatment. Never disregard professional medical advice or delay seeking it because of something you have read on this website.

References

[1] FDA Clarifies Policies Compounders National GLP-1 Supply Begins Stabilize – https://www.fda.gov/drugs/drug-alerts-and-statements/fda-clarifies-policies-compounders-national-glp-1-supply-begins-stabilize